Cargando…
Pharmacological ascorbate and ionizing radiation (IR) increase labile iron in pancreatic cancer()
Labile iron, i.e. iron that is weakly bound and is relatively unrestricted in its redox activity, has been implicated in both the pathogenesis as well as treatment of cancer. Two cancer treatments where labile iron may contribute to their mechanism of action are pharmacological ascorbate and ionizin...
Autores principales: | Moser, Justin C., Rawal, Malvika, Wagner, Brett A., Du, Juan, Cullen, Joseph J., Buettner, Garry R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881203/ https://www.ncbi.nlm.nih.gov/pubmed/24396727 http://dx.doi.org/10.1016/j.redox.2013.11.005 |
Ejemplares similares
-
Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate
por: Du, Juan, et al.
Publicado: (2021) -
The role of mitochondria in pharmacological ascorbate-induced toxicity
por: Du, Juan, et al.
Publicado: (2022) -
Pharmacologic Ascorbate and DNMT Inhibitors Increase DUOX Expression and Peroxide-Mediated Toxicity in Pancreatic Cancer
por: Steers, Garett J., et al.
Publicado: (2023) -
Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells
por: Brandt, Kristin E., et al.
Publicado: (2017) -
BIMG-07. PHARMACOLOGICAL ASCORBATE ENHANCES RADIATION AND TEMOZOLOMIDE EFFECTIVENESS IN GLIOBLASTOMA BY A MECHANISM MEDIATED BY REDOX ACTIVE IRON
por: Allen, Bryan, et al.
Publicado: (2021)